M. Rothe

Most-cited papers

1. Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells

   F. Lichtenegger, M. Rothe, Frauke M. Schnorfeil, K. Deiser +5 more

   2018Frontiers in Immunology166 citations Open access

   Semantic Scholar

   Save

2. Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC specific T-cell bispecific antibody.

   C. Augsberger, G. Hänel, Wei Xu, V. Pulko +32 more

   2021Blood65 citations Open access

   Semantic Scholar

   Save

3. Toll‐like receptor 7/8‐matured RNA‐transduced dendritic cells as post‐remission therapy in acute myeloid leukaemia: results of a phase I trial

   F. Lichtenegger, Frauke M. Schnorfeil, M. Rothe, K. Deiser +18 more

   2020Clinical & Translational Immunology37 citations Open access

   Semantic Scholar

   Save

4. Fusion of Bacterial Flagellin to a Dendritic Cell-Targeting αCD40 Antibody Construct Coupled With Viral or Leukemia-Specific Antigens Enhances Dendritic Cell Maturation and Activates Peptide-Responsive T Cells

   S. Schmitt, S. Tahk, A. Lohner, G. Hänel +11 more

   2020Frontiers in Immunology20 citations Open access

   Semantic Scholar

   Save

5. Induction of Antigen-Specific T-Cell Responses through Dendritic Cell Vaccination in AML: Results of a Phase I/II Trial and Ex Vivo Enhancement By Checkpoint Blockade

   F. Lichtenegger, K. Deiser, M. Rothe, Frauke M. Schnorfeil +14 more

   20168 citations

   Semantic Scholar

   Save

6. Targeting Intracellular WT1 in AML Utilizing a T Cell Bispecific Antibody Construct: Augmenting Efficacy through Combination with Lenalidomide

   C. Klein, Christian Augsberger, Wei Xu, Christina Heitmüller +17 more

   2019Blood5 citations Open access

   Semantic Scholar

   Save

7. Enhancing dendritic cell vaccination by immune checkpoint blockade as therapy in AML

   M. Rothe

   20200 citations

   Semantic Scholar

   Save

8. P04.04 Multifunctional antibody construct for in vivo targeting of dendritic cells as a therapeutic vaccination strategy in AML

   S. Schmitt, A. Lohner, K. Deiser, A. Maiser +8 more

   2020Journal for ImmunoTherapy of Cancer0 citations Open access

   Semantic Scholar

   Save

9. P04.09 Development of a dendritic cell vaccine against hepatocellular carcinoma using VSV-NDV

   J. Gold, L. Hanesch, T. Krabbe, C. Lozano-Simon +8 more

   2020Journal for ImmunoTherapy of Cancer0 citations Open access

   Semantic Scholar

   Save

10. PF207 TARGETING WILMS TUMOR 1 WITH A T CELL BISPECIFIC ANTIBODY (WT1-TCB): EX VIVO AND IN VIVO POTENCY BY BIVALENT RECOGNITION OF PEPTIDE-MHC COMPLEXES FROM AN INTRACELLULAR TUMOR ANTIGEN

    C. Augsberger, C. Klein, C. Heitmüller, Wei Xu +15 more

    2019HemaSphere0 citations Open access

    Semantic Scholar

    Save

11. Preclinical Development of Gene Therapy for X-Linked Severe Combined Immunodeficiency (SCID-X1)

    Poletti, S. Charrier, G. Corre, S. Martin +13 more

    20160 citations Open access

    Semantic Scholar

    Save

12. Pre-clinical development of lentiviral gene therapy for SCID-X1

    S. Charrier, Poletti, S. Martin, A. Vignaud +8 more

    20150 citations

    Semantic Scholar

    Save